Filing Flows › HeartSciences (HSCS) › Who owns the stock
Who owns HeartSciences (HSCS) stock
15 funds reported HeartSciences (HSCS) shares in their latest 13F filings, worth $368K in all. The largest holder is Geode Capital Management, LLC ($58K). Last quarter 5 funds added to their stakes and 6 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Geode Capital Management, LLC | 23,049 | $58K | decrease | 2026-06-30 |
| Vanguard Group | 18,556 | $57K | unchanged | 2025-12-31 |
| Astoria Strategic Wealth | 18,927 | $48K | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 17,968 | $45K | unchanged | 2026-06-30 |
| Vanguard Fiduciary Trust | 17,239 | $43K | unchanged | 2026-06-30 |
| Tradition Wealth Management, LLC | 16,819 | $42K | unchanged | 2026-06-30 |
| Citadel Advisors LLC | 14,488 | $36K | new | 2026-06-30 |
| Citigroup | 5,859 | $15K | new | 2026-06-30 |
| UBS Group AG | 5,812 | $15K | decrease | 2026-06-30 |
| Tower Research Capital LLC | 1,568 | $4K | decrease | 2026-06-30 |
| BlackRock | 750 | $2K | new | 2026-06-30 |
| Federation des caisses Desjardins du Quebec | 700 | $2K | unchanged | 2026-06-30 |
| Osaic Holdings | 650 | $2K | increase | 2026-06-30 |
| Financial Management Professionals | 2 | $5 | new | 2026-06-30 |
| Barclays | 1 | $4 | new | 2026-09-30 |
HeartSciences' latest quarter
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most HSCS stock?
By the latest 13F filings: Geode Capital Management, LLC ($58K); Vanguard Group ($57K); Astoria Strategic Wealth ($48K); Vanguard Capital Management LLC ($45K); Vanguard Fiduciary Trust ($43K).
What is the short interest in HSCS?
63,146 shares were sold short at the 2026-10-15 settlement, 126.08% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.